The monohydrate form of levobupivacaine hydrochloride. A piperidinecarboxamide-based local anaesthetic, it has a slow onset and long duration of action.
Stars
This entity has been manually annotated by the ChEBI Team.
An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Ca2+-transporting ATPase (EC 3.6.3.8).
Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
has part
levobupivacaine hydrochloride (anhydrous)
(CHEBI:31772)
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
has role
adrenergic antagonist
(CHEBI:37887)
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
has role
amphiphile
(CHEBI:59941)
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
has role
EC 3.1.1.8 (cholinesterase) inhibitor
(CHEBI:37733)
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
has role
EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor
(CHEBI:60186)
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
has role
local anaesthetic
(CHEBI:36333)
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
is a
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride hydrate
(CHEBI:77449)
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
is enantiomer of
dextrobupivacaine hydrochloride hydrate
(CHEBI:77454)
Incoming
bupivacaine hydrochloride hydrate
(CHEBI:60789)
has part
levobupivacaine hydrochloride hydrate
(CHEBI:77453)
dextrobupivacaine hydrochloride hydrate
(CHEBI:77454)
is enantiomer of
levobupivacaine hydrochloride hydrate
(CHEBI:77453)